The purpose of this study is to investigate the impact of exercise training, Acarbose, and
the combination of exercise and Acarbose on glycemic control, body composition, insulin
sensitivity and other cardiovascular risk markers in type 2 diabetes. Further, muscle
biopsies will be obtain to study gene expression. Our hypothesis is that the combination
therapy will be superior to monotherapy with exercise or Acarbose.
Phase:
Phase 4
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Bayer The Swedish Medical Research Council The Swedish Research Council